In a report released on September 11, Daina Graybosch from Leerink Partners maintained a Buy rating on Merck & Company (MRK ... (I-DXd), a potential new standard-of-care for second-line ...

This marks Keytruda's first approval for the given indication. Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

What’s next for Akeso and Summit Therapeutics after their cancer immunotherapy outperformed Merck’s Keytruda in ... We also discuss the latest news in the life sciences, including Moderna ...

development of new cancer or death by 37% over solo chemotherapy used only in the presurgery, neoadjuvant phase. The 2021 approval came a few months after the FDA rejected Merck’s original bid ...

Columbus Blue Jackets standout Johnny Gaudreau and his younger brother have died after being struck by a vehicle while riding bikes in New Jersey, the team and National Hockey League (NHL ...

The cousin of an FBI trainee who illegally obtained information about a planned Merck & Co acquisition from ... Harvey Weinstein pleaded not guilty to a new sexual assault charge on Wednesday ...

In the wake of Merck’s latest setback, the search for a viable PD-1/L1 inhibitor in stage 1 or 2 unresected NSCLC is still ongoing for at least one other company. AstraZeneca is conducting the ...

See our latest analysis for Merck ROE can be calculated by using the formula: Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity So, based on the above formula ...

Keep up with the latest options trades for Merck & Co with Benzinga Pro for real-time alerts. Benzinga is an innovative financial news outlet that has become the first choice for brokerages given ...

Merck (NYSE: MRK) is a top pharmaceutical company ... One of the keys to replacing the lost revenue will be new drugs, including Winrevair, a treatment for pulmonary arterial hypertension.